<unk>  is an antibody-drug conjugate that is FDA approved for the treatment of hodgkin's lymphoma, systemic anaplastic large cell lymphoma. There is a Black Box Warning for this drug as shown here.  Common adverse reactions include neutropenia, sensory neuropathy.
Brentuximab vedotin
Volociximab
Abiciximab
Dinutuximab
Dabrafenib mesylate
Bavituximab
Neratinib
Dasatinib